Sam Isaly, managing partner of OrbiMed Investors and portfolio manager of the Worldwide Healthcare trust, says strategically-driven M&A activity and leaps in scientific research are continuing to drive growth for the sector
Driven by secular tailwinds and advances in scientific research, the MSCI World Healthcare index has returned 10.74% on an annualised basis over the past ten years. In 2013 and 2014 alone the index returned 37.1% and 18.7% respectively. To put the performance into context, the MSCI World index has managed an annualised return of 6.7% over the previous 10 years. Can companies within the global healthcare sector maintain the momentum? Investors remembering the sell-off of biotechnology stocks in March 2014, will be wary that as the index pushes ever new heights, a correction could be i...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes